6505--Sevelamer Carbonate Tablets

SOL #: 36E79726R0023Solicitation

Overview

Buyer

Veterans Affairs

Veterans Affairs, Department Of

NAC PHARMACEUTICALS (36E797)

HINES, IL, 60141, United States

Place of Performance

Place of performance not available

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Original Source

https://sam.gov/opp/af2a6c331e1b429888b7d313fdd5c0db/view

Timeline

Posted

Apr 23, 2026

Last Updated

May 28, 2026

Submission Deadline

Jun 16, 2026, 7:30 PM

Qualification Details

Fit reasons

NAICS alignment with historical contract wins in similar service areas.
Scope strongly matches core technical capabilities and delivery model.

Risks

Past performance thresholds may require one additional teaming partner.
Potential clarification needed on staffing minimums before bid/no-bid.

Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA), through its NAC PHARMACEUTICALS office, is soliciting proposals for Sevelamer Carbonate 800mg Tablets (270 tablets per bottle). This unrestricted opportunity aims to establish VA National Contract prices for pharmaceutical products distributed via the VA and DoD Pharmaceutical Prime Vendor Programs. Proposals are due June 16, 2026, at 2:30 PM CT.

Scope of Work & Key Requirements

This solicitation seeks a reliable source of supply for Sevelamer Carbonate 800mg Tablets, with an estimated annual usage of 42,891 bottles. Key requirements include:

Product: Sevelamer Carbonate 800mg Tablets, 270 Tablets per Bottle (Unit of Use).
Packaging: Unit of use bottles must feature a safety cap (convertible to non-safety), a minimum 120cc volume, a cylindrical body with a 5.75” circumference, and space to fit a 5.25” x 2” label with an additional 0.5” for barcode/expiration/lot number.
National Drug Code (NDC): Offerors must provide a unique 11-digit NDC for each drug offered.
Manufacturer Commitment: Non-manufacturing offerors must submit a Letter of Commitment from the manufacturer.
Compliance: Products must meet FDA cGMP standards. Bar code labeling (GS1-128 or HIBCC) is required at the unit-of-use package level, and compliance with Drug Supply Chain Security Act (DSCSA) requirements for serialized transaction information is mandatory.

Contract Details

Contract Type: Firm Fixed Price, Indefinite-Delivery Requirements contract.
Period of Performance: One base year plus four one-year option periods.
Distribution: Products will be distributed through Government Prime Vendor contract(s) for VA, DoD, Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).

Submission & Evaluation

Submission: Proposals must be submitted via email to Matthew.Poulin@va.gov and Teresa.Hussain@va.gov. Submissions should be Microsoft Word or PDF files and include a scanned PDF of the signed SF-1449. Faxed proposals are not accepted.
Pricing: Offerors must provide pricing for the base year and all four option years for line item 1, including a 0.5% Cost Recovery Fee. Prices must not exceed two decimal places.
Evaluation: Award will be made to the responsible offeror with the Lowest Price Technically Acceptable (LPTA) offer. Technical acceptability criteria include meeting product descriptions, FDA approval, FDA cGMP compliance, and verifiable manufacturing facility clearance.
Deadline: The closing date for receipt of offers is June 16, 2026, at 2:30 PM CT. Offerors must acknowledge any amendments.

Eligibility & Set-Aside

This acquisition is unrestricted.
Offerors must maintain a current and accurate record in the System for Award Management (SAM).
Subcontracting plans are required for contracts over $900,000 if the offeror is not a small business.